PHBI
PHBI company profile
Latest price
As of — · Market data by Massive
Market cap
—
Volume
—
Previous close
—
Day range
—
Listed
—
Coverage
7 articles
Price performance
Recent trading
Newsroom
Latest PHBI coverage
PHBI Pharmagreen Biotech Appoints Ethan Styles as Vice President of Product Research and Development
[ad_1] Carson City, NV – (NewMediaWire) – September 22, 2022 – Pharmagreen Biotech, Inc., (OTCQB: PHBI), (“Pharmagreen” or the “Company) is pleased to announce that Ethan Styles has joined the Pharmagreen team in the role of Vice President of Product Research and Development. Mr. Styles’ lifelong work with therapeutic plants, cannabis, medi
NewMediaWire | PHBI – Pharmagreen Biotech Provides Updates on Its Ongoing Business Developments
[ad_1] Carson City, NV – (NewMediaWire) – March 24, 2022 – Pharmagreen Biotech, Inc., (OTCQB: PHBI), (“Pharmagreen” or the “Company”) is pleased to report ongoing business developments with Long Valley Farms (“LVF”) while completing its fundraising for the acquisition. LVF is continuing its applications processes for the nursery license as
Pharmagreen Prepares for Entry Into the Multi-Billion Dollar California Cannabis Industry
[ad_1] CARSON CITY, NV – (NewMediaWire) – November 11, 2021 – Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), is pleased to announce that in advance of its entry into the multi-billion dollar California cannabis industry and the development of its Tissue Culture Centre, the company has engaged its research and development corporate partner to
Pharmagreen Provides Company Update For Its Shareholders
[ad_1] Carson City, NV – (NewMediaWire) – April 28, 2021 – Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), is pleased to update its shareholders on the company’s developments and progress. With the balance sheet cleaned up, recent company filing, PHBI intends to move forward with financing for further business developments. Pharmagreen’s man
Pharmagreen Removes Convertible Debt From Its Balance Sheet
[ad_1] Carson City, NV – (NewMediaWire) – March 23, 2021 – Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), is pleased to announce that it has signed a settlement agreement with one of the convertible note lenders to cease and desist any future conversions and considers this matter closed going forward. The settlement agreement was submitted
Pharmagreen Biotech Aims to Restructure Debt, Protect the Company and Its Shareholders
[ad_1] Carson City – (NewMediaWire) – August 11, 2020 – Pharmagreen Biotech, Inc. (OTC: PHBI), a company specializing in the development of highest quality tissue cultured starter plantlets for the cannabis and hemp industry, announced today that the Company has voluntarily filed for petitions for relief under chapter 11
Pharmagreen Provides Significant Scientific Development Updates
[ad_1] Carson City, NV – (NewMediaWire) – July 28, 2020 – Pharmagreen Biotech, Inc. (PHBI), a company specializing in the development of high quality tissue cultured starter plantlets for the cannabis and hemp industry, is pleased to provide a scientific development update. Since December 2019 the company’s strategic research and developmen